FDA Roundup: July 16, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-16-2024
FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products
http://www.fda.gov/news-events/press-announcements/fda-ftc-continue-joint-effort-protect-consumers-against-companies-illegally-selling-copycat-delta-8
FDA Roundup: July 12, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-12-2024
FDA Updates Guidance to Further Empower Companies to Address the Spread of Misinformation
http://www.fda.gov/news-events/press-announcements/fda-updates-guidance-further-empower-companies-address-spread-misinformation
FDA Roundup: July 5, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-5-2024
FDA Roundup: July 2, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-2-2024
FDA Roundup: June 28, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-28-2024
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
http://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-point-care-hepatitis-c-rna-test
FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
http://www.fda.gov/news-events/press-announcements/fda-guidance-provides-new-details-diversity-action-plans-required-certain-clinical-studies
FDA Roundup: June 25, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-25-2024
